Auralis

Auralis developed generic pharmaceutical products for niche markets, which were subject to licence or regulatory approval providing barriers to entry to protect margin and revenue.

Aquarius assisted management in developing a focussed asset portfolio strategy, which would shape the business to be either floated or would have the critical mass to be of interest to large trade acquirers.

www.auralis.co.uk